南非抗感染市场到 2027 年 - 按类型(抗菌、抗病毒和抗真菌)进行区域分析和预测;范围(广谱和窄谱)和分销渠道(医院药房、零售药房和邮购药房)

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 68    |    Report Code: TIPRE00006585    |    Category: Life Sciences

Explore in Your Language
South Africa Anti-Infective Market

南非抗感染市场预计将从 18.935 亿美元增至 2027 年的 25.725 亿美元

2018 年,该市场预计将以 3.6% 的复合年增长率增长。

 

市场的增长是由南非病毒性疾病病例增加等因素推动的。然而,由于南非对真菌感染缺乏认识,市场可能会受到影响。

 

根据 GHE 发布的数据,2018 年南非有近 752 万人感染艾滋病毒。此外,2017 年,大约 21% 的南非艾滋病毒感染者来自南非。预计 2018 年南非人口中艾滋病毒总体患病率接近 13.1%,而对于 15-49 岁的成年人,估计有 19.0% 的人口被发现艾滋病毒呈阳性。此外,南非是世界上肝癌发病率最高的国家之一,这与成年人乙肝病毒感染率升高有关。

 

<此外,头癣的发病率在南非也占主导地位。此外,该国的结核病和艾滋病毒感染人数较多,这进一步导致大量慢性肺曲霉病(CPA)病例。此外,海湾临床微生物学和传染病会议上公布的数据表明,南非约有 99,350 例 CPA 病例。患病率接近175/10万,是全球患病率最高的。此外,根据疾病预防控制中心2019年4月公布的数据显示,2012-2016年,耳念珠菌影响了全国近451名患者。因此,由于全国范围内的流行率不断上升,可能会在预测期内推动抗感染市场的增长。

 

南方非洲抗感染药市场根据分销渠道分为医院药房、零售药房和网上药房。 2018年,按分销渠道划分,医院药房细分市场占据最大市场份额。预计该细分市场在预测期内将以最高速度增长。

 

 

图表:南非在线药店市场收入及 2027 年预测(百万美元)


 


亚太地区糖尿病护理设备 –市场细分


按类型

  • 抗菌
  • 抗病毒
  • 抗真菌

< strong>

应用

  • 广谱
  • < span>窄谱


按分销渠道

  • 医院药房
  • 零售药房
  • 网上药房
< p>


公司简介

  • 赛诺菲
  • 雅培
  • 葛兰素史克公司
  • 辉瑞公司
  • 默克公司&有限公司
  • 拜耳股份公司
  • 强生公司约翰逊服务公司
  • 山德士国际有限公司
  • 阿斯彭控股
  • < span>安斯泰来制药公司


South Africa Anti-Infective Strategic Insights

Strategic insights for South Africa Anti-Infective involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-africa-anti-infective-market-strategic-framework.webp
Get more information on this report

South Africa Anti-Infective Report Scope

Report Attribute Details
Market size in 2018 US$ 1,893.5 Million
Market Size by 2027 US$ 2,572.5 Million
Global CAGR (2019 - 2027) 3.6%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 类型
  • 抗菌
  • 抗病毒和抗真菌
By 范围
  • 广谱
  • 窄谱
By 分销渠道
  • 医院药房
  • 零售药房
  • 邮购药房
Regions and Countries Covered 南非
  • 南非
Market leaders and key company profiles
  • Sanofi
  • Abbott
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Sandoz International GmbH
  • Aspen Holdings
  • Astellas Pharma Inc.
  • Get more information on this report

    South Africa Anti-Infective Regional Insights

    The regional scope of South Africa Anti-Infective refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-africa-anti-infective-market-geography.webp
    Get more information on this report

    The List of Companies - South Africa Anti-Infective Market

    The List of Companies

    1. Sanofi
    2. Abbott
    3. GlaxoSmithKline plc.
    4. Pfizer Inc.
    5. Merck & Co. Inc.
    6. Bayer AG
    7. Johnson & Johnson Services, Inc.
    8. Sandoz International GmbH
    9. Aspen Holdings
    10. Astellas Pharma Inc.

     

    Frequently Asked Questions
    How big is the South Africa Anti-Infective Market?

    The South Africa Anti-Infective Market is valued at US$ 1,893.5 Million in 2018, it is projected to reach US$ 2,572.5 Million by 2027.

    What is the CAGR for South Africa Anti-Infective Market by (2019 - 2027)?

    As per our report South Africa Anti-Infective Market, the market size is valued at US$ 1,893.5 Million in 2018, projecting it to reach US$ 2,572.5 Million by 2027. This translates to a CAGR of approximately 3.6% during the forecast period.

    What segments are covered in this report?

    The South Africa Anti-Infective Market report typically cover these key segments-

  • 类型 (抗菌, 抗病毒和抗真菌)
  • 范围 (广谱, 窄谱)
  • 分销渠道 (医院药房, 零售药房, 邮购药房)
  • What is the historic period, base year, and forecast period taken for South Africa Anti-Infective Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South Africa Anti-Infective Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in South Africa Anti-Infective Market?

    The South Africa Anti-Infective Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Sanofi
  • Abbott
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Sandoz International GmbH
  • Aspen Holdings
  • Astellas Pharma Inc.
  • Who should buy this report?

    The South Africa Anti-Infective Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South Africa Anti-Infective Market value chain can benefit from the information contained in a comprehensive market report.